APA (7th ed.) Citation

Polyakov, A. S., Tyrenko, V. V., Kryukov, E. V., & Noskov, Y. A. (2021). Optimal choice of prophylactic anticoagulant therapy for nonvalvular atrial fibrillation in the context of COVID-19 pandemic. «FIRMA «SILICEA» LLC.

Chicago Style (17th ed.) Citation

Polyakov, A. S., V. V. Tyrenko, E. V. Kryukov, and Ya. A. Noskov. Optimal Choice of Prophylactic Anticoagulant Therapy for Nonvalvular Atrial Fibrillation in the Context of COVID-19 Pandemic. «FIRMA «SILICEA» LLC, 2021.

MLA (9th ed.) Citation

Polyakov, A. S., et al. Optimal Choice of Prophylactic Anticoagulant Therapy for Nonvalvular Atrial Fibrillation in the Context of COVID-19 Pandemic. «FIRMA «SILICEA» LLC, 2021.

Warning: These citations may not always be 100% accurate.